Patents
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
11/2001
11/15/2001US20010041799 Diephenyl carbocyclic thioamide derivatives
11/15/2001US20010041798 Processes and intermediates in the synthesis of 5-(3-{exo-bicyclo{2.2.1}hept-2-yloxy]-4-methoxyphenyl)-3,4,5,6- tetrahydropyrimidin-2(1H)-one
11/15/2001US20010041707 Selective antagonists for human alpha 1a receptors; benign prostatic hyperplasia; (+)-1-3-((4-(3,4-difluorophenyl)-2,5-dioxo-1,2,5,7-tetrahydro-4H-furo(3,4 -d)pyrimidine-3-carbonyl)amino)-propyl-4-(2-pyridyl)-piperidine
11/15/2001DE10023085A1 Arylamino and aralkylamino substituted quinoline and quinazoline derivatives, useful for the treatment of e.g. tumors, pulmonary, respiratory and gastrointestinal disorders and psoriasis
11/15/2001CA2409729A1 5-ht7 receptor antagonists
11/15/2001CA2406512A1 Pharmaceutical compounds for treating copd
11/15/2001CA2404987A1 (e)-7(4-fluorophenyl)-6isopropyl2-mesylaminopyrimidin-5-y)-(3r,5s)-dihydroxyhept-6-enoic acid.
11/14/2001EP1153921A2 Cyclic ureas and analogues useful as retroviral protease inhibitors
11/14/2001EP1153920A1 Quinoline derivatives and quinazoline derivatives
11/14/2001EP1153015A1 Pyrimidine-2,4,6-triones as inhibitors of matrix metalloproteinases
11/14/2001EP1153014A2 Beta-alanine derivatives
11/14/2001EP0815087B1 Trisubstituted phenyl derivatives
11/14/2001EP0672041B1 Pharmacologically active pyridine derivatives and processes for the preparation thereof
11/14/2001CN1322198A HIV replication inhibiting pyrimidines
11/13/2001US6316595 PNA synthesis using a base-labile amino protecting group
11/13/2001US6316482 Benzamide derivatives having a vasopressin antagonistic activity
11/13/2001US6316478 IL-8 receptor antagonists
11/13/2001US6316460 Containing a heptenoic acid derivative and a tribasic phosphate salt as a stabilizer; hmg-coa reductase inhibitor
11/13/2001US6316457 Nitrosated and nitrosylated phosphodiesterase inhibitor compounds, compositions and their uses
11/13/2001US6316455 Method of improving the effectiveness of a cytotoxic drug or radiotherapy using a quinazolinone compound
11/13/2001US6316454 Inducing apoptosis and preventing metastases of brain tumor cells
11/13/2001US6316389 Dihydrobenzene pesticides
11/08/2001WO2001083460A1 Cyclic compounds
11/08/2001WO2001083459A2 Uracil substituted phenyl sulfamoyl carboxamides
11/08/2001WO2001083427A1 PPARη MODULATORS
11/08/2001WO2001083421A1 Process for the preparation of 2-halobenzoic acids
11/08/2001WO2001032632A3 Pharmaceutically active 4-substituted pyrimidine derivatives
11/08/2001US20010039344 Antidiabetic agents
11/08/2001US20010039343 Pesticides, fungicides, herbicides, insecticides, microbiocdes, drugs
11/08/2001CA2407587A1 Ppar.gamma. modulators
11/08/2001CA2407231A1 Cyclic compounds
11/07/2001EP1150964A2 Polycyclic pyrimidine-2,4(1h, 3h)-dione with functionalized alkyl radicals in 1- and/or 3-position, method for the production thereof and pharmaceutical preparations
11/07/2001EP1150963A1 Substituted 4-amino-2-aryltetrahydroquinazolines, their preparation, their use and pharmaceutical compositions comprising them
11/07/2001EP1150962A1 Process for the preparation of 6-(perfluoroalkyl)uracil compounds from carbamate compounds
11/07/2001EP1150948A1 ALKENYL AND ALKYNYL COMPOUNDS AS INHIBITORS OF FACTOR Xa
11/07/2001EP1150944A1 N2-phenylamidine derivatives
11/07/2001EP1150937A1 Liquid crystalline trifluoro-substituted compounds
11/07/2001EP1150679A1 Use of cholesterol-lowering agent
11/07/2001EP0946474B1 1,3-difluoronapthalene derivatives for liquid crystal mixtures
11/07/2001EP0626939B1 Tri-substituted phenyl derivatives as phosphodiesterase inhibitors
11/07/2001CN1321151A Chemical compounds
11/07/2001CN1321150A Amide derivs. useful as inhibitors of production of cytokines
11/07/2001CN1320426A Compound for treatment of female sexual dysfuction
11/07/2001CN1320375A Herbicidal synergic composition and method for controlling weed
11/07/2001CN1320374A Herbicidal synergic composition and method for controlling weed
11/07/2001CN1320373A Herbicidal synergic composition and method for controlling weed
11/06/2001US6313296 2-pyrrolidinone-1-acetic acid derivatives; viricides for human immunodeficiency virus (hiv); acquired immune deficiency syndrome (aids) treatment
11/06/2001US6313139 Administering benzylamine derivative for therapy of psychiatric disorder in mammals
11/06/2001US6313129 Therapeutic compounds
11/06/2001US6313127 For therapy of hypercholesterolemia or atherosclerosis
11/06/2001US6313120 Treatment or prevention of diseases involving bradykinin receptors
11/06/2001US6313119 Vitronectin receptor antagonists
11/06/2001US6313088 Carriers used to deliver various active agents through various biological, chemical, and physical barriers
11/06/2001US6313072 Herbicidal 2-aryloxy-or 2-arylthio-6-arylpyrimidines
11/06/2001US6312538 Chemical compound suitable for use as an explosive, intermediate and method for preparing the compound
11/01/2001WO2001081346A2 Inhibitors of human phosphatidyl-inositol 3-kinase delta
11/01/2001WO2001081335A1 Pyrimidine-sulfonamides having endothelin-antagonist activity
11/01/2001WO2001081334A2 Cyclic amidine compounds and their use as alpha4beta2 nicotinic acetylcholine receptor ligands
11/01/2001WO2001081319A2 Ultrashort acting hypnotic barbiturates
11/01/2001WO2001038311A3 Pyrimidine derivatives as selective inhibitors of cox-2
11/01/2001US20010037039 Non-peptidic; inhibits trypsin-like protease, thrombin and embolus formation; anticoagulant
11/01/2001US20010036936 Compositions and methods for treating osteoporosis
11/01/2001US20010036930 Therapeutic azide compounds
11/01/2001CA2404898A1 Ultrashort acting hypnotic barbiturates
11/01/2001CA2372673A1 Cyclic amidine compounds
10/2001
10/31/2001EP1149885A1 Cyclohexane derivatives, liquid crystal compositions comprising the same and liquid crystal display devices
10/31/2001EP1149834A1 Diaminopyrimidines, pharmaceutical compositions containing them and their use as antibacterial
10/31/2001EP1149091A1 4-(heterocyclylsulfonamido)-5-methoxy-6-(2-methoxyphenoxy)-2-phenyl- or pyridylpyrimidines as endothelin receptor antagonists
10/31/2001EP1149066A1 Method of preparing alkylated salicylamides
10/31/2001EP0888292B1 TRICYCLIC COMPOUNDS HAVING ACTIVITY SPECIFIC FOR INTEGRINS, PARTICULARLY ALPHAvBETA3 INTEGRINS, METHOD FOR PREPARING SAME, INTERMEDIATES THEREFOR, USE OF SAID COMPOUNDS AS DRUGS, AND PHARMACEUTICAL COMPOSITIONS CONTAINING SAME
10/31/2001EP0767782B1 Aryl and heteroaryl alkoxynaphthalene derivatives
10/31/2001DE10019291A1 2-Alkoxy-5-methoxypyrimidine bzw. deren tautomere Formen sowie Verfahren zu ihrer Herstellung 2-alkoxy-5-methoxypyrimidine, or their tautomeric forms, as well as processes for their preparation
10/31/2001CN1319592A Process for preparing 2-methyl-4-amino-5-amino methylpyrimidine
10/31/2001CN1319396A Medicinal composition
10/30/2001US6310204 5,5-bis(difluoramino)hexahydro-1,3-dinitropyrimidine (RNFX) and certain electronegatively substituted pyrimidines
10/30/2001US6310178 Ureins derived from α, ω-diamino acids and process for their preparation
10/30/2001US6310096 Cyclohexadiene-derivatives as pesticides
10/30/2001US6310095 Inhibitors of protein isoprenyl transferases
10/30/2001US6310071 Fungicides, insecticides, miticides, nematocides
10/30/2001US6310069 Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them and their use in the treatment of diabetes and related diseases
10/30/2001US6309561 Liquid crystal compounds having a chiral fluorinated terminal portion
10/25/2001WO2001079189A2 'amides of r-2-(aminoaryl)-propionic acids for use in theprevention of leucocyte activation'
10/25/2001WO2001079185A1 Novel amino carboxy alkyl derivatives of barbituric acid
10/25/2001WO2001079172A1 Vitronectin receptor antagonist bicyclic compounds, preparation method and compositions containing same
10/25/2001WO2001079159A1 NOVEL α-SULFIN- AND α-SULFONAMINO ACID AMIDES
10/25/2001WO2001079157A1 Hydrazide and alkoxyamide angiogenesis inhibitors
10/25/2001WO2001049288A9 Novel compounds and compositions as protease inhibitors
10/25/2001US20010034351 A quinazoline compound
10/25/2001DE10019062A1 Use of known and new 2-guanidino-4-aryl-quinazoline derivatives as NHE-3 inhibitors useful for the treatment of e.g. hypertension, thrombosis, cardiac ischemia, peripheral and CNS ischemia
10/25/2001CA2406442A1 Hydrazide and alkoxyamide angiogenesis inhibitors
10/25/2001CA2406396A1 Novel amino carboxy alkyl derivatives of barbituric acid
10/25/2001CA2403563A1 Novel .alpha.-sulfin- and .alpha.-sulfonamino acid amides
10/24/2001EP1148056A1 Herbicidal benzoyloxy carboxylates and carboxamides
10/24/2001EP1147162A1 Ferroelectric active matrix displays with wide operating temperature range
10/24/2001EP1147093A1 Substituted bicyclic derivatives useful as anticancer agents
10/24/2001EP1147091A2 Fused ring heteroaryl and heterocyclic compounds which inhibit leukocyte adhesion mediated by vla-4
10/24/2001EP0775142B1 Substituted o6 -benzylguanines
10/24/2001EP0648212B1 Benzoxazole and benzothiazole derivatives as pharmaceutical
10/24/2001CN1319096A Quinazoline derivatives and pharmaceutical applications thereof
10/24/2001CN1319092A Benzamide derivatives and their use as cytokine inhibitors